Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:35 PM
Ignite Modification Date: 2025-12-25 @ 12:11 PM
NCT ID: NCT02230761
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT02230761
Study Brief: Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
XOPH5 Ointment XOPH5 Ointment is the investigational drug to be studied. XOPH5 Ointment None None 0 60 11 60 View
Placebo Ointment Placebo is an ointment that matches XOPH5 Ointment but lacks the active ingredient. Placebo None None 1 30 0 30 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Guillan-Barre syndrome SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hyperemia eyelid (mild, transient) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Increase in vellus hair (mild) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View